Skip to content

Cross-sectional Survey on Adherence to Inhaler Therapy, Satisfaction, Symptom Control, and Pulmonary Function Assessment in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Clinical comprehensive evaluation of inhalation therapies in COPD patients.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116969
Enrollment
Unknown
Registered
2026-01-18
Start date
2025-07-31
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Observational group:None

Sponsors

The First Affiliated Hospital of Shihezi University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with COPD as outpatients or inpatients; 2. Patients receiving inhaler therapy; 3. Complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Patients with neurological or psychiatric disorders who are unable to cooperate with treatment; 2. Patients with severe hepatic or renal insufficiency; 3. Patients with advanced-stage malignant tumors.

Design outcomes

Primary

MeasureTime frame
Effectiveness: clinical outcomes, CAT score, mMRC score, frequency and severity of acute exacerbations.;Safety: incidence of adverse reactions, drug interactions.;Economic: healthcare cost burden, insurance coverage, etc.;

Countries

China

Contacts

Public ContactWang Xiaoyi

The First Affiliated Hospital of Shihezi University

1369881248@qq.com+86 152 9943 1226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026